nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC22A5—Dactinomycin—kidney cancer	0.275	1	CbGbCtD
Cefdinir—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.0125	1	CbGdCrCtD
Cefdinir—SLC15A1—nephron tubule—kidney cancer	0.0028	0.11	CbGeAlD
Cefdinir—SLC15A1—renal system—kidney cancer	0.00254	0.0999	CbGeAlD
Cefdinir—SLC15A1—kidney—kidney cancer	0.00246	0.0966	CbGeAlD
Cefdinir—MPO—renal system—kidney cancer	0.00229	0.0899	CbGeAlD
Cefdinir—MPO—kidney—kidney cancer	0.00221	0.0869	CbGeAlD
Cefdinir—SLC15A2—nephron tubule—kidney cancer	0.00175	0.0687	CbGeAlD
Cefdinir—SLC15A2—renal system—kidney cancer	0.00159	0.0625	CbGeAlD
Cefdinir—SLC15A2—kidney—kidney cancer	0.00154	0.0604	CbGeAlD
Cefdinir—SLC22A5—nephron tubule—kidney cancer	0.00152	0.0598	CbGeAlD
Cefdinir—SLC15A2—cortex of kidney—kidney cancer	0.0015	0.0588	CbGeAlD
Cefdinir—SLC22A5—renal system—kidney cancer	0.00138	0.0543	CbGeAlD
Cefdinir—SLC22A5—kidney—kidney cancer	0.00134	0.0525	CbGeAlD
Cefdinir—SLC22A5—cortex of kidney—kidney cancer	0.0013	0.0511	CbGeAlD
Cefdinir—SLC22A5—cardiac atrium—kidney cancer	0.00124	0.0486	CbGeAlD
Cefdinir—Gastrointestinal pain—Erlotinib—kidney cancer	0.000641	0.000933	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—kidney cancer	0.000638	0.000929	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—kidney cancer	0.000635	0.000924	CcSEcCtD
Cefdinir—Leukopenia—Vincristine—kidney cancer	0.00063	0.000917	CcSEcCtD
Cefdinir—Thrombocytopenia—Dactinomycin—kidney cancer	0.000629	0.000916	CcSEcCtD
Cefdinir—Pancytopenia—Capecitabine—kidney cancer	0.000625	0.00091	CcSEcCtD
Cefdinir—Dyspepsia—Sorafenib—kidney cancer	0.000621	0.000904	CcSEcCtD
Cefdinir—Abdominal pain—Erlotinib—kidney cancer	0.00062	0.000902	CcSEcCtD
Cefdinir—Body temperature increased—Erlotinib—kidney cancer	0.00062	0.000902	CcSEcCtD
Cefdinir—Neutropenia—Capecitabine—kidney cancer	0.000615	0.000896	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—kidney cancer	0.000615	0.000895	CcSEcCtD
Cefdinir—Insomnia—Sunitinib—kidney cancer	0.000614	0.000894	CcSEcCtD
Cefdinir—Decreased appetite—Sorafenib—kidney cancer	0.000613	0.000893	CcSEcCtD
Cefdinir—Anorexia—Dactinomycin—kidney cancer	0.000613	0.000892	CcSEcCtD
Cefdinir—Nausea—Pazopanib—kidney cancer	0.000611	0.00089	CcSEcCtD
Cefdinir—Convulsion—Vincristine—kidney cancer	0.000609	0.000887	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000609	0.000887	CcSEcCtD
Cefdinir—Hypertension—Vincristine—kidney cancer	0.000607	0.000884	CcSEcCtD
Cefdinir—Erythema multiforme—Paclitaxel—kidney cancer	0.000607	0.000884	CcSEcCtD
Cefdinir—Constipation—Sorafenib—kidney cancer	0.000603	0.000878	CcSEcCtD
Cefdinir—Hypersensitivity—Vinblastine—kidney cancer	0.000601	0.000875	CcSEcCtD
Cefdinir—Hypersensitivity—Everolimus—kidney cancer	0.000599	0.000872	CcSEcCtD
Cefdinir—Dyspepsia—Sunitinib—kidney cancer	0.000597	0.00087	CcSEcCtD
Cefdinir—Leukopenia—Gemcitabine—kidney cancer	0.000597	0.00087	CcSEcCtD
Cefdinir—Pneumonia—Capecitabine—kidney cancer	0.00059	0.000859	CcSEcCtD
Cefdinir—Decreased appetite—Sunitinib—kidney cancer	0.00059	0.000859	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000586	0.000853	CcSEcCtD
Cefdinir—Asthenia—Vinblastine—kidney cancer	0.000585	0.000852	CcSEcCtD
Cefdinir—Asthenia—Everolimus—kidney cancer	0.000583	0.000849	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000582	0.000847	CcSEcCtD
Cefdinir—Constipation—Sunitinib—kidney cancer	0.00058	0.000845	CcSEcCtD
Cefdinir—Acute coronary syndrome—Capecitabine—kidney cancer	0.000578	0.000842	CcSEcCtD
Cefdinir—Gastrointestinal pain—Sorafenib—kidney cancer	0.000577	0.00084	CcSEcCtD
Cefdinir—Renal failure—Capecitabine—kidney cancer	0.000577	0.00084	CcSEcCtD
Cefdinir—Hypertension—Gemcitabine—kidney cancer	0.000576	0.000839	CcSEcCtD
Cefdinir—Myocardial infarction—Capecitabine—kidney cancer	0.000575	0.000837	CcSEcCtD
Cefdinir—Pruritus—Everolimus—kidney cancer	0.000575	0.000837	CcSEcCtD
Cefdinir—Anaphylactic shock—Vincristine—kidney cancer	0.000574	0.000836	CcSEcCtD
Cefdinir—Jaundice—Capecitabine—kidney cancer	0.000572	0.000833	CcSEcCtD
Cefdinir—Stomatitis—Capecitabine—kidney cancer	0.000572	0.000833	CcSEcCtD
Cefdinir—Conjunctivitis—Capecitabine—kidney cancer	0.00057	0.00083	CcSEcCtD
Cefdinir—Chest pain—Gemcitabine—kidney cancer	0.000568	0.000827	CcSEcCtD
Cefdinir—Asthenia—Erlotinib—kidney cancer	0.000563	0.000819	CcSEcCtD
Cefdinir—Thrombocytopenia—Vincristine—kidney cancer	0.000562	0.000818	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000562	0.000818	CcSEcCtD
Cefdinir—Haematuria—Capecitabine—kidney cancer	0.000559	0.000814	CcSEcCtD
Cefdinir—Decreased appetite—Dactinomycin—kidney cancer	0.000559	0.000813	CcSEcCtD
Cefdinir—Diarrhoea—Vinblastine—kidney cancer	0.000558	0.000813	CcSEcCtD
Cefdinir—Abdominal pain—Sorafenib—kidney cancer	0.000558	0.000812	CcSEcCtD
Cefdinir—Body temperature increased—Sorafenib—kidney cancer	0.000558	0.000812	CcSEcCtD
Cefdinir—Diarrhoea—Everolimus—kidney cancer	0.000556	0.00081	CcSEcCtD
Cefdinir—Gastrointestinal pain—Sunitinib—kidney cancer	0.000555	0.000808	CcSEcCtD
Cefdinir—Pruritus—Erlotinib—kidney cancer	0.000555	0.000808	CcSEcCtD
Cefdinir—Flatulence—Paclitaxel—kidney cancer	0.000551	0.000802	CcSEcCtD
Cefdinir—Agranulocytosis—Capecitabine—kidney cancer	0.000548	0.000797	CcSEcCtD
Cefdinir—Anorexia—Vincristine—kidney cancer	0.000547	0.000797	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—kidney cancer	0.000546	0.000795	CcSEcCtD
Cefdinir—Anaphylactic shock—Gemcitabine—kidney cancer	0.000545	0.000793	CcSEcCtD
Cefdinir—Dizziness—Vinblastine—kidney cancer	0.000539	0.000785	CcSEcCtD
Cefdinir—Dizziness—Everolimus—kidney cancer	0.000537	0.000782	CcSEcCtD
Cefdinir—Body temperature increased—Sunitinib—kidney cancer	0.000537	0.000781	CcSEcCtD
Cefdinir—Abdominal pain—Sunitinib—kidney cancer	0.000537	0.000781	CcSEcCtD
Cefdinir—Diarrhoea—Erlotinib—kidney cancer	0.000536	0.000781	CcSEcCtD
Cefdinir—Thrombocytopenia—Gemcitabine—kidney cancer	0.000533	0.000776	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—kidney cancer	0.000532	0.000774	CcSEcCtD
Cefdinir—Haemoglobin—Capecitabine—kidney cancer	0.000529	0.000771	CcSEcCtD
Cefdinir—Haemorrhage—Capecitabine—kidney cancer	0.000527	0.000767	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000525	0.000765	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00052	0.000757	CcSEcCtD
Cefdinir—Hypersensitivity—Sorafenib—kidney cancer	0.00052	0.000757	CcSEcCtD
Cefdinir—Insomnia—Vincristine—kidney cancer	0.000519	0.000756	CcSEcCtD
Cefdinir—Anorexia—Gemcitabine—kidney cancer	0.000519	0.000756	CcSEcCtD
Cefdinir—Vomiting—Vinblastine—kidney cancer	0.000519	0.000755	CcSEcCtD
Cefdinir—Dizziness—Erlotinib—kidney cancer	0.000519	0.000755	CcSEcCtD
Cefdinir—Vomiting—Everolimus—kidney cancer	0.000517	0.000752	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—kidney cancer	0.000516	0.000751	CcSEcCtD
Cefdinir—Agitation—Paclitaxel—kidney cancer	0.000513	0.000748	CcSEcCtD
Cefdinir—Rash—Everolimus—kidney cancer	0.000512	0.000746	CcSEcCtD
Cefdinir—Dermatitis—Everolimus—kidney cancer	0.000512	0.000745	CcSEcCtD
Cefdinir—Headache—Vinblastine—kidney cancer	0.000511	0.000744	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—kidney cancer	0.000509	0.000741	CcSEcCtD
Cefdinir—Headache—Everolimus—kidney cancer	0.000509	0.000741	CcSEcCtD
Cefdinir—Abdominal pain—Dactinomycin—kidney cancer	0.000508	0.00074	CcSEcCtD
Cefdinir—Body temperature increased—Dactinomycin—kidney cancer	0.000508	0.00074	CcSEcCtD
Cefdinir—Asthenia—Sorafenib—kidney cancer	0.000506	0.000737	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—kidney cancer	0.000503	0.000732	CcSEcCtD
Cefdinir—Leukopenia—Paclitaxel—kidney cancer	0.0005	0.000728	CcSEcCtD
Cefdinir—Hypersensitivity—Sunitinib—kidney cancer	0.0005	0.000728	CcSEcCtD
Cefdinir—Decreased appetite—Vincristine—kidney cancer	0.000499	0.000727	CcSEcCtD
Cefdinir—Pruritus—Sorafenib—kidney cancer	0.000499	0.000727	CcSEcCtD
Cefdinir—Vomiting—Erlotinib—kidney cancer	0.000499	0.000726	CcSEcCtD
Cefdinir—Erythema multiforme—Capecitabine—kidney cancer	0.000498	0.000725	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vincristine—kidney cancer	0.000496	0.000722	CcSEcCtD
Cefdinir—Rash—Erlotinib—kidney cancer	0.000494	0.00072	CcSEcCtD
Cefdinir—Dermatitis—Erlotinib—kidney cancer	0.000494	0.000719	CcSEcCtD
Cefdinir—Insomnia—Gemcitabine—kidney cancer	0.000493	0.000717	CcSEcCtD
Cefdinir—Headache—Erlotinib—kidney cancer	0.000491	0.000715	CcSEcCtD
Cefdinir—Loss of consciousness—Paclitaxel—kidney cancer	0.000491	0.000715	CcSEcCtD
Cefdinir—Constipation—Vincristine—kidney cancer	0.000491	0.000715	CcSEcCtD
Cefdinir—Asthenia—Sunitinib—kidney cancer	0.000487	0.000709	CcSEcCtD
Cefdinir—Nausea—Vinblastine—kidney cancer	0.000485	0.000705	CcSEcCtD
Cefdinir—Somnolence—Gemcitabine—kidney cancer	0.000484	0.000705	CcSEcCtD
Cefdinir—Convulsion—Paclitaxel—kidney cancer	0.000484	0.000705	CcSEcCtD
Cefdinir—Nausea—Everolimus—kidney cancer	0.000483	0.000703	CcSEcCtD
Cefdinir—Diarrhoea—Sorafenib—kidney cancer	0.000483	0.000703	CcSEcCtD
Cefdinir—Hypertension—Paclitaxel—kidney cancer	0.000482	0.000702	CcSEcCtD
Cefdinir—Pruritus—Sunitinib—kidney cancer	0.00048	0.000699	CcSEcCtD
Cefdinir—Chest pain—Paclitaxel—kidney cancer	0.000476	0.000693	CcSEcCtD
Cefdinir—Decreased appetite—Gemcitabine—kidney cancer	0.000473	0.000689	CcSEcCtD
Cefdinir—Hypersensitivity—Dactinomycin—kidney cancer	0.000473	0.000689	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00047	0.000685	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vincristine—kidney cancer	0.000469	0.000683	CcSEcCtD
Cefdinir—Dizziness—Sorafenib—kidney cancer	0.000466	0.000679	CcSEcCtD
Cefdinir—Constipation—Gemcitabine—kidney cancer	0.000466	0.000678	CcSEcCtD
Cefdinir—Nausea—Erlotinib—kidney cancer	0.000466	0.000678	CcSEcCtD
Cefdinir—Dry mouth—Paclitaxel—kidney cancer	0.000465	0.000677	CcSEcCtD
Cefdinir—Diarrhoea—Sunitinib—kidney cancer	0.000464	0.000676	CcSEcCtD
Cefdinir—Asthenia—Dactinomycin—kidney cancer	0.000461	0.000671	CcSEcCtD
Cefdinir—Anaphylactic shock—Paclitaxel—kidney cancer	0.000456	0.000664	CcSEcCtD
Cefdinir—Body temperature increased—Vincristine—kidney cancer	0.000454	0.000661	CcSEcCtD
Cefdinir—Abdominal pain—Vincristine—kidney cancer	0.000454	0.000661	CcSEcCtD
Cefdinir—Flatulence—Capecitabine—kidney cancer	0.000452	0.000658	CcSEcCtD
Cefdinir—Dizziness—Sunitinib—kidney cancer	0.000449	0.000653	CcSEcCtD
Cefdinir—Shock—Paclitaxel—kidney cancer	0.000449	0.000653	CcSEcCtD
Cefdinir—Vomiting—Sorafenib—kidney cancer	0.000449	0.000653	CcSEcCtD
Cefdinir—Thrombocytopenia—Paclitaxel—kidney cancer	0.000446	0.00065	CcSEcCtD
Cefdinir—Rash—Sorafenib—kidney cancer	0.000445	0.000648	CcSEcCtD
Cefdinir—Dermatitis—Sorafenib—kidney cancer	0.000444	0.000647	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000442	0.000643	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000442	0.000643	CcSEcCtD
Cefdinir—Headache—Sorafenib—kidney cancer	0.000442	0.000643	CcSEcCtD
Cefdinir—Diarrhoea—Dactinomycin—kidney cancer	0.00044	0.00064	CcSEcCtD
Cefdinir—Anorexia—Paclitaxel—kidney cancer	0.000435	0.000633	CcSEcCtD
Cefdinir—Vomiting—Sunitinib—kidney cancer	0.000432	0.000628	CcSEcCtD
Cefdinir—Body temperature increased—Gemcitabine—kidney cancer	0.000431	0.000627	CcSEcCtD
Cefdinir—Rash—Sunitinib—kidney cancer	0.000428	0.000623	CcSEcCtD
Cefdinir—Dermatitis—Sunitinib—kidney cancer	0.000428	0.000623	CcSEcCtD
Cefdinir—Headache—Sunitinib—kidney cancer	0.000425	0.000619	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—kidney cancer	0.000424	0.000618	CcSEcCtD
Cefdinir—Hypersensitivity—Vincristine—kidney cancer	0.000423	0.000616	CcSEcCtD
Cefdinir—Nausea—Sorafenib—kidney cancer	0.000419	0.00061	CcSEcCtD
Cefdinir—Insomnia—Paclitaxel—kidney cancer	0.000412	0.0006	CcSEcCtD
Cefdinir—Asthenia—Vincristine—kidney cancer	0.000412	0.0006	CcSEcCtD
Cefdinir—Leukopenia—Capecitabine—kidney cancer	0.00041	0.000598	CcSEcCtD
Cefdinir—Vomiting—Dactinomycin—kidney cancer	0.000409	0.000595	CcSEcCtD
Cefdinir—Somnolence—Paclitaxel—kidney cancer	0.000405	0.00059	CcSEcCtD
Cefdinir—Rash—Dactinomycin—kidney cancer	0.000405	0.00059	CcSEcCtD
Cefdinir—Nausea—Sunitinib—kidney cancer	0.000403	0.000587	CcSEcCtD
Cefdinir—Loss of consciousness—Capecitabine—kidney cancer	0.000403	0.000587	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—kidney cancer	0.000403	0.000586	CcSEcCtD
Cefdinir—Dyspepsia—Paclitaxel—kidney cancer	0.000401	0.000584	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—kidney cancer	0.000397	0.000577	CcSEcCtD
Cefdinir—Decreased appetite—Paclitaxel—kidney cancer	0.000396	0.000577	CcSEcCtD
Cefdinir—Hypertension—Capecitabine—kidney cancer	0.000396	0.000576	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000394	0.000573	CcSEcCtD
Cefdinir—Diarrhoea—Vincristine—kidney cancer	0.000393	0.000572	CcSEcCtD
Cefdinir—Asthenia—Gemcitabine—kidney cancer	0.000391	0.000569	CcSEcCtD
Cefdinir—Chest pain—Capecitabine—kidney cancer	0.00039	0.000568	CcSEcCtD
Cefdinir—Constipation—Paclitaxel—kidney cancer	0.00039	0.000568	CcSEcCtD
Cefdinir—Pruritus—Gemcitabine—kidney cancer	0.000385	0.000561	CcSEcCtD
Cefdinir—Dry mouth—Capecitabine—kidney cancer	0.000382	0.000556	CcSEcCtD
Cefdinir—Nausea—Dactinomycin—kidney cancer	0.000382	0.000556	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—kidney cancer	0.00038	0.000554	CcSEcCtD
Cefdinir—Dizziness—Vincristine—kidney cancer	0.00038	0.000553	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000375	0.000546	CcSEcCtD
Cefdinir—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000373	0.000543	CcSEcCtD
Cefdinir—Diarrhoea—Gemcitabine—kidney cancer	0.000373	0.000543	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—kidney cancer	0.000372	0.000541	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—kidney cancer	0.000369	0.000537	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—kidney cancer	0.000369	0.000537	CcSEcCtD
Cefdinir—Shock—Capecitabine—kidney cancer	0.000368	0.000536	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—kidney cancer	0.000368	0.000535	CcSEcCtD
Cefdinir—Thrombocytopenia—Capecitabine—kidney cancer	0.000366	0.000533	CcSEcCtD
Cefdinir—Vomiting—Vincristine—kidney cancer	0.000365	0.000531	CcSEcCtD
Cefdinir—Rash—Vincristine—kidney cancer	0.000362	0.000527	CcSEcCtD
Cefdinir—Dermatitis—Vincristine—kidney cancer	0.000362	0.000527	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—kidney cancer	0.000361	0.000525	CcSEcCtD
Cefdinir—Body temperature increased—Paclitaxel—kidney cancer	0.00036	0.000525	CcSEcCtD
Cefdinir—Abdominal pain—Paclitaxel—kidney cancer	0.00036	0.000525	CcSEcCtD
Cefdinir—Headache—Vincristine—kidney cancer	0.00036	0.000524	CcSEcCtD
Cefdinir—Anorexia—Capecitabine—kidney cancer	0.000357	0.000519	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—kidney cancer	0.000353	0.000514	CcSEcCtD
Cefdinir—Vomiting—Gemcitabine—kidney cancer	0.000346	0.000504	CcSEcCtD
Cefdinir—Rash—Gemcitabine—kidney cancer	0.000343	0.0005	CcSEcCtD
Cefdinir—Dermatitis—Gemcitabine—kidney cancer	0.000343	0.000499	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—kidney cancer	0.000341	0.000497	CcSEcCtD
Cefdinir—Headache—Gemcitabine—kidney cancer	0.000341	0.000497	CcSEcCtD
Cefdinir—Nausea—Vincristine—kidney cancer	0.000341	0.000496	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—kidney cancer	0.00034	0.000494	CcSEcCtD
Cefdinir—Insomnia—Capecitabine—kidney cancer	0.000338	0.000493	CcSEcCtD
Cefdinir—Hypersensitivity—Paclitaxel—kidney cancer	0.000336	0.000489	CcSEcCtD
Cefdinir—Dyspepsia—Capecitabine—kidney cancer	0.000329	0.00048	CcSEcCtD
Cefdinir—Asthenia—Paclitaxel—kidney cancer	0.000327	0.000476	CcSEcCtD
Cefdinir—Decreased appetite—Capecitabine—kidney cancer	0.000325	0.000474	CcSEcCtD
Cefdinir—Nausea—Gemcitabine—kidney cancer	0.000324	0.000471	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000323	0.00047	CcSEcCtD
Cefdinir—Pruritus—Paclitaxel—kidney cancer	0.000323	0.00047	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—kidney cancer	0.000321	0.000467	CcSEcCtD
Cefdinir—Constipation—Capecitabine—kidney cancer	0.00032	0.000466	CcSEcCtD
Cefdinir—Diarrhoea—Paclitaxel—kidney cancer	0.000312	0.000454	CcSEcCtD
Cefdinir—Gastrointestinal pain—Capecitabine—kidney cancer	0.000306	0.000446	CcSEcCtD
Cefdinir—Dizziness—Paclitaxel—kidney cancer	0.000302	0.000439	CcSEcCtD
Cefdinir—Abdominal pain—Capecitabine—kidney cancer	0.000296	0.000431	CcSEcCtD
Cefdinir—Body temperature increased—Capecitabine—kidney cancer	0.000296	0.000431	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—kidney cancer	0.000291	0.000424	CcSEcCtD
Cefdinir—Vomiting—Paclitaxel—kidney cancer	0.00029	0.000422	CcSEcCtD
Cefdinir—Rash—Paclitaxel—kidney cancer	0.000288	0.000419	CcSEcCtD
Cefdinir—Dermatitis—Paclitaxel—kidney cancer	0.000287	0.000418	CcSEcCtD
Cefdinir—Headache—Paclitaxel—kidney cancer	0.000286	0.000416	CcSEcCtD
Cefdinir—Hypersensitivity—Capecitabine—kidney cancer	0.000276	0.000401	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—kidney cancer	0.000272	0.000395	CcSEcCtD
Cefdinir—Nausea—Paclitaxel—kidney cancer	0.000271	0.000394	CcSEcCtD
Cefdinir—Asthenia—Capecitabine—kidney cancer	0.000268	0.000391	CcSEcCtD
Cefdinir—Pruritus—Capecitabine—kidney cancer	0.000265	0.000385	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—kidney cancer	0.000265	0.000385	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—kidney cancer	0.00026	0.000378	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—kidney cancer	0.000256	0.000373	CcSEcCtD
Cefdinir—Diarrhoea—Capecitabine—kidney cancer	0.000256	0.000373	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—kidney cancer	0.000255	0.000372	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—kidney cancer	0.000252	0.000366	CcSEcCtD
Cefdinir—Dizziness—Capecitabine—kidney cancer	0.000247	0.00036	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—kidney cancer	0.000246	0.000358	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—kidney cancer	0.000241	0.000351	CcSEcCtD
Cefdinir—Vomiting—Capecitabine—kidney cancer	0.000238	0.000346	CcSEcCtD
Cefdinir—Shock—Doxorubicin—kidney cancer	0.000237	0.000346	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—kidney cancer	0.000236	0.000344	CcSEcCtD
Cefdinir—Rash—Capecitabine—kidney cancer	0.000236	0.000344	CcSEcCtD
Cefdinir—Dermatitis—Capecitabine—kidney cancer	0.000236	0.000343	CcSEcCtD
Cefdinir—Headache—Capecitabine—kidney cancer	0.000234	0.000341	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—kidney cancer	0.00023	0.000335	CcSEcCtD
Cefdinir—Nausea—Capecitabine—kidney cancer	0.000222	0.000324	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—kidney cancer	0.000218	0.000318	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—kidney cancer	0.000214	0.000312	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—kidney cancer	0.000212	0.000309	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—kidney cancer	0.00021	0.000305	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000208	0.000303	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—kidney cancer	0.000206	0.0003	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000197	0.000287	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—kidney cancer	0.000191	0.000278	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—kidney cancer	0.000191	0.000278	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—kidney cancer	0.000178	0.000259	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—kidney cancer	0.000173	0.000252	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—kidney cancer	0.000171	0.000248	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—kidney cancer	0.000165	0.00024	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—kidney cancer	0.00016	0.000232	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—kidney cancer	0.000153	0.000223	CcSEcCtD
Cefdinir—Rash—Doxorubicin—kidney cancer	0.000152	0.000221	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—kidney cancer	0.000152	0.000221	CcSEcCtD
Cefdinir—Headache—Doxorubicin—kidney cancer	0.000151	0.00022	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—kidney cancer	0.000143	0.000209	CcSEcCtD
